PAVM logo

PAVM
PAVmed Inc

9,244
Mkt Cap
$54.45M
Volume
17,409.00
52W High
$28.44
52W Low
$6.00
PE Ratio
-0.37
PAVM Fundamentals
Price
$8.53
Prev Close
$8.30
Open
$8.34
50D MA
$9.67
Beta
1.11
Avg. Volume
12,784.71
EPS (Annual)
-$5.63
P/B
0.85
Rev/Employee
$1,731.71
$29.26
Loading...
Loading...
News
all
press releases
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 PR Newswire...
PR Newswire·2d ago
News Placeholder
More News
News Placeholder
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on...
PR Newswire·3d ago
News Placeholder
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
PROCEPT BIOROBO (PRCT) delivered earnings and revenue surprises of -2.43% and +3.53%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock PR Newswire NEW YORK...
PR Newswire·9d ago
News Placeholder
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock PR Newswire NEW YORK, April 23, 2026 NEW...
PR Newswire·10d ago
News Placeholder
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual...
PR Newswire·24d ago
News Placeholder
PAVM Assigns Joseph Virgilio to Lead Medical Device Portfolio Relaunch
PAVmed taps industry veteran Joseph Virgilio to lead its device portfolio relaunch to boost growth, commercialization and long-term shareholder value.
Zacks·26d ago
News Placeholder
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio PR Newswire NEW YORK, April 2, 2026 Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical...
PR Newswire·1mo ago
News Placeholder
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know
PAVmed (PAVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·1mo ago
News Placeholder
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results PR...
PR Newswire·1mo ago
<
1
2
...
>

Latest PAVM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.